IL13 and systemic sclerosis: Indeed, evidence supports the pivotal role of type 2 inflammation in SSc pathogenesis, with increased T-helper type 2 (Th2)-polarized cell tissue infiltration and higher levels of circulating IL-4 and IL-13 (23).